TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36237549

about

Targeting microRNAs as key modulators of tumor immune response MicroRNA Targeting to Modulate Tumor Microenvironment MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer Hepatitis B Virus Infection, MicroRNAs and Liver Disease Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer Immune cell promotion of metastasis The role of miRNAs in regulating gene expression networks Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement TP53/MicroRNA Interplay in Hepatocellular Carcinoma Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas Inflammation and skeletal metastasis MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.The roles of TGFβ in the tumour microenvironment.Cancer-derived Circulating MicroRNAs Promote Tumor Angiogenesis by Entering Dendritic Cells to Degrade Highly Complementary MicroRNAs.MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma.Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.MicroRNAs associated with HBV infection and HBV-related HCC.Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum.MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation.Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study.The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer.MicroRNA-125b modulates inflammatory chemokine CCL4 expression in immune cells and its reduction causes CCL4 increase with age.MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-β Pathway.Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.Chemokines and their receptors play important roles in the development of hepatocellular carcinoma miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop

P2860

Q26746972-D9721AEE-E346-4899-9E71-2DB4E34CD7F1 Q26770275-8836588A-0C0D-4CD0-8B84-596D2D126170 Q26773183-099A424F-F5A1-43F2-8DF6-4C5CE01A4A42 Q26777313-F3BC352E-40BF-484A-9C12-59BC3A3E76A9 Q26801511-6C5841CC-D9F9-4A3A-8B1A-F265B1243F07 Q26823512-06ECE732-FB26-46F7-AABE-335528AA17FE Q26849525-6CD114BC-EF1B-47CE-8B45-500E0BF00E63 Q26991724-C7214763-9A9A-4E27-8019-F80DFCA189C6 Q26992175-28930B5D-3C24-4CA4-978F-5A26F4D0105A Q28066038-2C217F2A-EC8A-4981-A0ED-465288BC01E4 Q28073980-B7F89EC0-4C06-4E64-8F27-062C24B3F6BA Q28086980-C84933B4-46C2-423A-8C6B-2C92AEF6B5DA Q28087354-F29364A7-209E-473C-85AD-50A8C94CEC29 Q28396089-173418FF-EDEA-4D40-B8E0-55CF65E254FA Q30352893-3287C877-38F7-425D-BEBB-BF23C76F1E9A Q30574554-44C442D1-2BB6-4084-B8E0-E5CB305725CC Q33618617-D3429AF0-5ACC-4B31-9137-A30CFE31F256 Q33630432-876FB845-A00D-40A5-BE9A-188B9DB107B3 Q33630845-52C7AFB8-2E70-49A1-B666-134933A578B0 Q33703057-7B819D6B-9F2B-49A8-ABD6-4EA03B01F646 Q33733403-9E67E367-DA85-4D66-B316-4FB4E39D5746 Q33753714-0E2D92E0-7C36-4F0B-9733-BE1EDA59F3D2 Q33906361-78182159-70F2-4FAC-BDBF-501FBF66D95F Q33961656-86450CC2-BF92-40B5-870C-A53DD6CD42A8 Q34284404-6146D00E-9925-4DCD-AE5F-5536FF919519 Q34452728-57582121-57EF-4E2B-92B7-9961D2A73556 Q34977095-2EA62FA7-E6E1-496F-89AA-629527262831 Q35016950-952846F5-B656-41C3-A0AE-67AB1C36A71C Q35038304-D4EB43A4-9A35-46B9-8946-76ECAE78EB21 Q35076779-C0575E1A-2689-41DF-9CE3-DEAFB5D63838 Q35128168-89E83450-F5EF-44DC-99D0-54DF2DE3B313 Q35136610-3A0AB420-8604-46EA-A251-C984F725632C Q35154337-009BD830-047D-4822-8A20-BCFCABEC4A16 Q35192124-681C3D84-DBD3-4D13-8572-8CF3A39DC1DB Q35273569-E73BBCD3-B72F-4383-A7EE-45C224E991E8 Q35552063-4836A0E6-55F6-4CDB-A56B-EB385FDBCF2F Q35610932-48CFEF76-2377-48A2-98B8-0CE82F92AE29 Q35652772-486F5684-2F95-497C-A214-EA8D9E78B2FD Q35668771-FF5AB79F-FC29-4F49-AF40-9303E443E5B8 Q35677296-9F2460AC-EEFD-414E-82B5-03114E9E820C

P2860

TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36237549

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

TGF-β-miR-34a-CCL22 signaling- ...... tive hepatocellular carcinoma.

@ast

TGF-β-miR-34a-CCL22 signaling- ...... tive hepatocellular carcinoma.

@en

type

label

TGF-β-miR-34a-CCL22 signaling- ...... tive hepatocellular carcinoma.

@ast

TGF-β-miR-34a-CCL22 signaling- ...... tive hepatocellular carcinoma.

@en

prefLabel

TGF-β-miR-34a-CCL22 signaling- ...... tive hepatocellular carcinoma.

@ast

TGF-β-miR-34a-CCL22 signaling- ...... tive hepatocellular carcinoma.

@en

P1433

Q36237549-223A5A3A-EF58-4BBA-B979-9D9D722A0E10

P1476

Q36237549-54CC57B1-A003-4B34-B9DB-7AFC07F3DCD4

P2093

Q36237549-02B35575-4EEA-4752-9C77-B4A9D788D05B

Q36237549-10237F79-4326-4677-AD16-10D27C2316A6

Q36237549-31CB3704-6D8A-4F0B-AC35-978890C6C14C

Q36237549-39982B87-6A9D-4E5E-8C53-69804CB37D4C

Q36237549-446282E6-DF5E-4142-8347-A7384F1891D5

Q36237549-BA699CDF-9628-4987-A05E-C621166FF407

Q36237549-C2D9E452-8A62-4DA0-8D84-794FE0ABB40E

Q36237549-C4347A81-A481-4FA0-BCC9-8FCBB87F7B91

Q36237549-DE2490D0-4CEC-4EB0-AEB4-5B6EDCC6F374

Q36237549-F1B94FC2-4985-4CD9-BC9B-A5DCF67176FC

P2860

Q36237549-13F177C9-7022-4E44-BA15-25150991342E

Q36237549-1E50E0B0-BCDE-4C0D-9D62-4F22A12F41B5

Q36237549-2236F929-3156-4001-A319-E5A2E054B83B

Q36237549-2965EC26-2225-4FC9-B411-6D51B563DF76

Q36237549-309935D8-1BD6-430C-8825-B1322D9913E9

Q36237549-3CEBB351-0259-446F-ACDE-1A4143B86FFF

Q36237549-3EA1624B-DFBD-47B3-89C3-5E5C09CE86BD

Q36237549-3F3D3E62-6A9D-44D3-93D4-B20710FD35B5

Q36237549-511D6AF6-64FE-4EC8-8794-C4FF3D74D77C

Q36237549-52186510-4616-4C49-B594-5B0B9A690412

P304

Q36237549-899AE7C3-F415-40CF-A362-F1B8DC400805

P31

Q36237549-B450E97F-DFBF-47E3-B774-FE2E8351D609

P356

Q36237549-B349DCBC-8AAB-4BB2-B8A9-D80C62ED3D9E

P433

Q36237549-BF9FB641-773D-4888-9554-75C377CCCB59

P478

Q36237549-C48FA839-F650-4621-A40A-EFE97C87346A

P50

Q36237549-0DDD1778-2819-40A7-ADA4-663B313F7CFB

Q36237549-70939AA8-373B-4E3F-90E8-19B7928AAC38

P577

Q36237549-739F9DD2-4327-4DAD-BCEB-0DCB4E7EBE4E

P5875

Q36237549-07B982E4-003D-46E7-82B0-2510FBBD564F

P698

Q36237549-9CFBD83F-DD64-429B-BC62-2D15DE1AD6FB

P932

Q36237549-020E2116-40F6-433A-8D2D-410F2FB67AE6

P356

J.CCR.2012.07.023

P1433

P1476

TGF-β-miR-34a-CCL22 signaling- ...... itive hepatocellular carcinoma

@en

P2093

Dong Xie

http://www.w3.org/2001/XMLSchema#string

Geoffrey J Markowitz

http://www.w3.org/2001/XMLSchema#string

Hong-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Jiangsha Zhao

http://www.w3.org/2001/XMLSchema#string

Pengyuan Yang

http://www.w3.org/2001/XMLSchema#string

Qi-Jing Li

http://www.w3.org/2001/XMLSchema#string

Shan Jiang

http://www.w3.org/2001/XMLSchema#string

Shanglei Ning

http://www.w3.org/2001/XMLSchema#string

Shu-Qun Cheng

http://www.w3.org/2001/XMLSchema#string

Xiao-Fan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Global cancer statistics, 2002

Oncomirs - microRNAs with a role in cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

TGFbeta in Cancer

A microRNA component of the p53 tumour suppressor network

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Dissemination and growth of cancer cells in metastatic sites

P304

291-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2012.07.023

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230848782

http://www.w3.org/2001/XMLSchema#string

P698

22975373

http://www.w3.org/2001/XMLSchema#string

P932

3443566

http://www.w3.org/2001/XMLSchema#string